Abstract
Korupcijska tveganja in korupcija v zdravstvu ostajajo globalni problem, na katerega Slovenija ni imuna. Pregled literature, virov in izvedba pilotske študije, ki je vključevala polstrukturirane intervjuje z zdravniki, strokovnjakom s področja omejevanja korupcije in dobaviteljem/zastopnikom, proizvajalci/distributerji zdravil in medicinskih pripomočkov, je nakazal, da v Sloveniji prevladujejo štiri pojavne oblike korupcije in korupcijskih tveganj v zdravstvu. Te so korupcija in korupcijska tveganja, izhajajoča iz sodelovanja s proizvajalci/distributerji zdravil in medicinskih pripomočkov, korupcija in korupcijska tveganja na področju javnih naročil, korupcija in korupcijska tveganja pri prepletu med javnimi in zasebnimi praksami ter korupcija in korupcijska tveganja v povezavi s čakalnimi vrstami. Močno je izražena tudi verjetnost, da je v slovenskem zdravstvenem sistemu prisotna sistemska korupcija. Za omejevanje korupcije in koruptivnih tveganj se kažejo kot najbolj efektivni pristopi k večanju transparentnega delovanja zdravstvenega sistema in terjanju odgovornosti ključnih akterjev, centraliziran sistem javnih naročil ter ureditev čakalnih vrst.
Keywords
korupcija;korupcijsko tveganje;Slovenija;zdravstvo;medicina;
Data
Language: |
Slovenian |
Year of publishing: |
2022 |
Typology: |
0 - Not set |
Organization: |
UM FVV - Faculty of Criminal Justice |
Publisher: |
Univerza v Mariboru, Univerzitetna založba |
UDC: |
614.2:343.3.352(082)(0.034.2) |
COBISS: |
139786499
|
ISBN: |
978-961-286-690-7 |
Views: |
18 |
Downloads: |
1 |
Average score: |
0 (0 votes) |
Metadata: |
|
Other data
Secondary language: |
English |
Secondary title: |
Coruption and (Slovenian) Healthcare |
Secondary abstract: |
Corruption and (Slovenian)Healthcare: Corruption risks and corruption in healthcare remain a global problem to which Slovenia is not immune. Desk research and a pilot study, which included semi-structural interviews with physicians, anti-corruption experts and manufacturers/distributor of manufacturers and distributors of medicines and medical devices, indicated that four forms of corruption and corruption risks prevail in Slovenian healthcare. These are corruption and corruption risks arising from cooperation with manufacturers/distributors of medicines and medical devices, corruption and corruption risks in the field of public procurement, corruption and corruption risks in the intertwining of public and private practices and corruption, and corruption risks relating to waiting lists. There is a high probability that systemic corruption is present in the Slovenian health care system. To limit corruption and corruption risks, the most effective approaches are to increase the transparency of the health system and hold key actors accountable, a centralized public procurement system must be implemented as well as proper waiting lines management. |
Secondary keywords: |
corruption;corruption risk;Slovenia;healthcare;medicine; |
Type (COBISS): |
Proceedings |
DOI: |
10.18690/um.fvv.1.2023 |
ID: |
17890462 |